.jpg)
Pfizer’s plot to win the RSV vaccine race
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: finance
STAT+: Biotech startups post strongest financing numbers in two years
The numbers are in, and biotech startups recently closed out their best fundraising quarter in…
HCA’s charity care filings are on hyperdrive
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
.jpg)
Sanofi resolves most Zantac litigation
Want to stay on top of the science and politics driving biotech today? Sign up to get…
How resurrecting extinct species might impact medicine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
New data on liquid biopsy for colorectal cancer detection still underwhelms
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Lawmakers want to add more Chinese biotechs to defense list
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Aardvark Therapeutics gearing up for $200 million IPO
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What’s Congress going to do with WuXi?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Brazil’s plan for low-cost CAR-Ts
New biotech newsletter launching tomorrow. Don’t miss out. Good morning, everyone. Damian here with the…
Merck’s next big thing is (probably) on the way
New biotech newsletter launching this Thursday. Don’t miss out. Hello, everyone. Damian here with a look…
BioNTech is having its Pfizer moment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What happens when an approved drug doesn’t work?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Prescription for resilience: Health care needs financial sector-inspired regulation
In the early days after it was hit by a cyberattack on Feb. 21, Change…
Geron’s resurgence might have been short-lived
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Preventing the weaponization of AI-designed proteins
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Banning WuXi is more complicated than it might sound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Nursing home owners can hide nearly two-thirds of their profits, new study shows
A new study shows that some nursing homes are shunting the majority of their profits…
Bayer’s not breaking up. At least not yet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Startup Alumis raises $259 million as it prepares for psoriasis trial
San Francisco startup Alumis Inc. has raised $259 million in a bid to best big…
Despite good data, Ironwood’s shares plummet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Listen: Legal insider trading, booming biotech stocks, & the next GLP-1
Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy? We cover…
The next act for a biotech rainmaker
Want to stay on top of the science and politics driving biotech today? Sign up to…
STAT+: An inside look at PIPEs, the financing trend that has biotech abuzz
Biotech is awash in PIPEs. The numbers behind these privately negotiated purchases of public-company stock…
Beam is trading like it’s 2021
Want to stay on top of the science and politics driving biotech today? Sign up to get…
GSK pill works in uncomplicated gonorrhea
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The FDA isn’t afraid to yank a disappointing drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Replicate’s srRNA rabies vaccine effective in Phase 1
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Private equity investment in Medicare Advantage drops
Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing…
STAT+: Lasers, cardiology, clinical trials: 2023’s top private equity targets
By some measures, private equity investment lagged in 2023, a year marked by growing distress…
Vertex still knows how to do what it does best
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Devoted Health’s losses in Medicare Advantage persist
Devoted Health has been one of the most prominent health insurance and provider startups of…
What makes a drug a blockbuster — or a cautionary tale?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novavax is on thin ice, and the latest update isn’t exactly encouraging
Want to stay on top of the science and politics driving biotech today? Sign up to…
Cigna to sell Medicare Advantage plans to Blue Cross Blue Shield insurer for $3.3 billion
Cigna is officially exiting the Medicare business, agreeing to sell all of its Medicare insurance…
23andMe breach targeted Chinese, Jewish populations
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Eli Lilly overtakes Tesla in market value
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: FTC sues to block a proposed hospital deal in North Carolina
The federal government is suing to block a proposed hospital deal in North Carolina, alleging…
STAT+: Humana projects a tough road for Medicare Advantage, sinking its stock
Humana’s Medicare Advantage business is faring even worse than the company let on last week,…
Another step toward new drugs for Parkinson’s
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Medicare Advantage update pushes Wall Street to reset expectations
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Investigators fault Lilly plant for manufacturing issues
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The Senate health committee looks into its first subpoena in 40 years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Humana slashes profit predictions amid soaring Medicare Advantage costs
Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often…
The XBI comedown after JPM
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The big any-day-now biotech news we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The four biotech stories you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novartis reportedly decides to pass on Cytokinetics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Nonprofit health systems plug their strong cash reserves at JPM — a very different pitch than they make elsewhere
SAN FRANCISCO — Hospital leaders spent a good chunk of their stage time at the…